Literature DB >> 19896963

Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain.

Elizabeth Crowe1, Christian Sell, Jeff D Thomas, Gregg J Johannes, Claudio Torres.   

Abstract

The insulin-like growth factor type 1 (IGF-I) plays an important role in neuronal physiology. Reduced IGF-I levels are observed during aging and this decrease may be important to age-related changes in the brain. We studied the effects of IGF-I on total protein oxidation in brain tissues and in cell cultures. Our results indicate that in frontal cortex the level of oxidized proteins is significantly reduced in transgenic mice designed to overproduce IGF-I compared with wild-type animals. The frontal cortex of IGF-I-overproducing mice exhibited high chymotrypsin-like activity of the 20S and 26S proteasomes. The proteasome can also be activated in response to IGF-I in cell cultures. Kinetic studies revealed peak activation of the proteasome within 15 min following IGF-I stimulation. The effects of IGF-I on proteasome were not observed in R(-) cells lacking the IGF-I receptor. Experiments using specific kinase inhibitors suggested that activation of proteasome by IGF-I involves phosphatidyl inositol 3-kinase and mammalian target of rapamycin signaling. IGF-I also attenuated the increase in protein carbonyl content induced by proteasome inhibition. Thus, appropriate levels of IGF-I may be important for the elimination of oxidized proteins in the brain in a process mediated by activation of the proteasome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896963      PMCID: PMC2821674          DOI: 10.1016/j.mad.2009.10.005

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  66 in total

Review 1.  The proteasome and its role in the degradation of oxidized proteins.

Authors:  Tobias Jung; Tilman Grune
Journal:  IUBMB Life       Date:  2008-11       Impact factor: 3.885

Review 2.  Structure and functions of the 20S and 26S proteasomes.

Authors:  O Coux; K Tanaka; A L Goldberg
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 3.  Ubiquitin, proteasomes, and the regulation of intracellular protein degradation.

Authors:  M Hochstrasser
Journal:  Curr Opin Cell Biol       Date:  1995-04       Impact factor: 8.382

4.  Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice.

Authors:  K Reiss; W Cheng; A Ferber; J Kajstura; P Li; B Li; G Olivetti; C J Homcy; R Baserga; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency.

Authors:  G Lembo; H A Rockman; J J Hunter; H Steinmetz; W J Koch; L Ma; M P Prinz; J Ross; K R Chien; L Powell-Braxton
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Role of insulin-like growth factors in embryonic and postnatal growth.

Authors:  J Baker; J P Liu; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons.

Authors:  K D Beck; L Powell-Braxton; H R Widmer; J Valverde; F Hefti
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

9.  Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.

Authors:  M A Hussain; O Schmitz; A Mengel; A Keller; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 10.  Expanding the mind: insulin-like growth factor I and brain development.

Authors:  A Joseph D'Ercole; Ping Ye
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

View more
  8 in total

1.  Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells.

Authors:  Benxu Cheng; Shivani Kaushal Maffi; Alex Anthony Martinez; Yolanda P Villarreal Acosta; Liza D Morales; James L Roberts
Journal:  Mol Cell Neurosci       Date:  2011-04-23       Impact factor: 4.314

2.  Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span.

Authors:  Antonello Lorenzini; Adam B Salmon; Chad Lerner; Claudio Torres; Yuji Ikeno; Susan Motch; Roger McCarter; Christian Sell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-07-20       Impact factor: 6.053

Review 3.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 4.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

5.  iRhom1 regulates proteasome activity via PAC1/2 under ER stress.

Authors:  WonJae Lee; YoungDoo Kim; Jisu Park; SangMi Shim; Jieun Lee; Se-hoon Hong; Hye-Hyun Ahn; Huikyong Lee; Yong-Keun Jung
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

Review 6.  Insulin Peptides as Mediators of the Impact of Life Style in Alzheimer's disease.

Authors:  A M Fernandez; A Santi; I Torres Aleman
Journal:  Brain Plast       Date:  2018-12-12

7.  Histological and Gene Expression Analysis of the Effects of Menopause Status and Hormone Therapy on the Vaginal Introitus and Labia Majora.

Authors:  Robert L Binder; Murray A Freedman; Kailash B Sharma; Miranda A Farage; Yu Wang; Chelsea Combs; David Moore; Jay P Tiesman; Charles C Bascom; Robert J Isfort; Raphael Warren
Journal:  J Clin Med Res       Date:  2019-10-29

8.  Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions.

Authors:  Weiyi Shen; Jiamin He; Tongyao Hou; Jianmin Si; Shujie Chen
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.